We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXYN
4751
DELISTED
Dixie Group Inc
DXYN
$4.7K ﹤0.01%
7,170
+4
+0.1% +$3
GUTS icon
4752
Fractyl Health
GUTS
$112M
$4.66K ﹤0.01%
1,092
-4,357
-80% -$28K
USXF icon
4753
iShares ESG Advanced MSCI USA ETF
USXF
$1.5B
$4.66K ﹤0.01%
+100
New +$4.47K
ECDA
4754
DELISTED
ECD Automotive Design
ECDA
$4.66K ﹤0.01%
19
+16
+533% +$3.54K
ENZ
4755
DELISTED
Enzo Biochem, Inc.
ENZ
$4.65K ﹤0.01%
4,263
-7,850
-65% -$8.84K
VTAK icon
4756
Catheter Precision
VTAK
$1.04M
$4.64K ﹤0.01%
42
+1
+2% +$102
JCPB icon
4757
JPMorgan Core Plus Bond ETF
JCPB
$14.1B
$4.63K ﹤0.01%
100
– –
MITQ icon
4758
Moving iMage Technologies
MITQ
$5.51M
$4.62K ﹤0.01%
7,432
+25
+0.3% +$14
E icon
4759
ENI
E
$78.9B
$4.62K ﹤0.01%
+150
New +$4.76K
BLNE
4760
Beeline Holdings
BLNE
$32.8M
$4.62K ﹤0.01%
444
-486
-52% -$5.02K
CALC icon
4761
CalciMedica
CALC
$10.3M
$4.61K ﹤0.01%
921
-1,260
-58% -$6.35K
SGOL icon
4762
abrdn Physical Gold Shares ETF
SGOL
$7.42B
$4.6K ﹤0.01%
207
-644
-76% -$14.4K
TNON icon
4763
Tenon Medical
TNON
$2.41M
$4.59K ﹤0.01%
27
-1
-4% -$212
SGLY icon
4764
Singularity Future Technology
SGLY
$6.27M
$4.59K ﹤0.01%
+66
New +$4.32K
SSKN
4765
DELISTED
Strata Skin Sciences
SSKN
$4.58K ﹤0.01%
1,492
+297
+25% +$1.21K
GLDM icon
4766
SPDR Gold MiniShares Trust
GLDM
$29.7B
$4.56K ﹤0.01%
99
-279
-74% -$12.9K
TELO icon
4767
Telomir Pharmaceuticals
TELO
$81.2M
$4.56K ﹤0.01%
+948
New +$5.92K
LX
4768
LexinFintech Holdings
LX
$237M
$4.55K ﹤0.01%
2,757
+1,486
+117% +$2.63K
BRKHU
4769
DELISTED
BurTech Acquisition Corp. Unit
BRKHU
$4.55K ﹤0.01%
385
– –
CVKD icon
4770
Cadrenal Therapeutics
CVKD
$7.14M
$4.54K ﹤0.01%
644
+9
+1% +$62
STIM icon
4771
Neuronetics
STIM
$146M
$4.54K ﹤0.01%
+2,524
New +$7.28K
STLN
4772
Starling Oncology, Inc. Common Stock
STLN
$607M
$4.52K ﹤0.01%
9,832
+2,080
+27% +$1.77K
USIG icon
4773
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$4.52K ﹤0.01%
+90
New +$4.5K
MAGS icon
4774
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
$4.24B
$4.51K ﹤0.01%
+100
New +$4.09K
NEON icon
4775
Neonode
NEON
$17.1M
$4.5K ﹤0.01%
2,173
-3,171
-59% -$6.78K
189 190
191
192 193

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.